Edition:
United States

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

1.96USD
14 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$1.96
Open
$1.93
Day's High
$1.97
Day's Low
$1.93
Volume
12,390
Avg. Vol
77,477
52-wk High
$6.94
52-wk Low
$1.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.46 -0.904
Jun '18 0.85 -0.439
Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.605
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.69 1.02 0.50 1.60
Quarter Ending Mar-19 2 0.90 1.00 0.80 1.50
Year Ending Dec-18 7 9.62 10.06 9.34 5.67
Year Ending Dec-19 7 18.03 30.40 7.00 18.24
Earnings (per share)
Quarter Ending Dec-18 5 -0.32 -0.22 -0.36 -0.57
Quarter Ending Mar-19 2 -0.34 -0.31 -0.36 -0.42
Year Ending Dec-18 7 -2.09 -1.95 -2.19 -2.31
Year Ending Dec-19 7 -1.14 -0.74 -1.46 -2.35
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta -- 0.66 0.95
Price to Sales (TTM) 12.95 242.95 21.76
Price to Book (MRQ) 1.33 18.87 4.53
Price to Tangible Book (MRQ) 1.34 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -68.60 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 53.46 61.53 5.26
Sales - 5 Yr. Growth Rate -- 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -14.25 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 90.70 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate -- 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 7.35 6.87 3.68
LT Debt to Equity (MRQ) 0.74 16.70 9.53
Total Debt to Equity (MRQ) 0.74 21.89 13.39
Interest Coverage (TTM) -140.61 -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -1,054.49 -- --
EBITD - 5 Yr. Avg -- -141.70 16.27
Operating Margin (TTM) -1,059.78 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -- -155.53 11.89
Pre-Tax Margin (TTM) -1,060.10 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- -157.11 12.22
Net Profit Margin (TTM) -1,064.19 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -- -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 113,420 28,103,806 878,349,382
Net Income/Employee (TTM) -1,207,011 -3,710,889 102,474,711
Receivable Turnover (TTM) 1.81 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.09 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -91.43 0.35 11.06
Return on Assets - 5 Yr. Avg. -- 2.90 11.85
Return on Investment (TTM) -105.72 0.60 13.80
Return on Investment - 5 Yr. Avg. -- 2.87 15.17
Return on Equity (TTM) -106.45 -2.18 15.29
Return on Equity - 5 Yr. Avg. -- -0.88 16.29
  1 Year 3 Year 5 Year
Sales % -17.94 -- --
EPS (TTM) % 90.25 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.98 -3.96 92 99
13 Week -28.25 -22.49 69 94
26 Week -56.24 -56.11 28 96
52 Week -69.32 -70.24 26 98
YTD -67.73 -67.83 28 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 56.91%
# of Holders: 54
Total Shares Held: 38,120,892
3 Mo. Net Change: 15,280,357
# New Positions: 14
# Closed Positions: 13
# Increased Positions: 35
# Reduced Positions: 22
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.